# Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD

> **NCT05094765** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shenzhen Xbiome Biotech Co., Ltd.** · enrollment: 15 (estimated)

## Conditions studied

- GVHD

## Interventions

- **BIOLOGICAL:** FMT

## Key facts

- **NCT ID:** NCT05094765
- **Lead sponsor:** Shenzhen Xbiome Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-02
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05094765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05094765, "Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05094765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*